Hypertriglyceridemia
Conditions
Interventions
IPE treatment group:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. On the basis of dietary control, triglyceride (TG) level >=5.6 mmol/L, OR a diagnosis of cardiovascular disease or diabetes mellitus accompanied by at least two other cardiovascular disease risk factors and TG >=1.7 mmol/L; 2. Presence of insulin resistance (HOMA-IR >=2); 3. Age >=18 years; 4. Receiving IPE treatment for at least 3 months during the enrollment period; 5. Signed informed consent must be obtained prior to enrollment in the study.
Exclusion criteria
Exclusion criteria: 1. Presence of severe liver or kidney disease, malignant tumors, or other serious illnesses with an expected life expectancy of no more than 1 year; 2. Participation in other interventional studies during the study period; 3. Receipt of IPE treatment within 1 year prior to screening; 4. Pregnancy or breastfeeding; 5. Any other condition that, in the investigator's judgment, would place the subject at significant risk if they participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Homeostatic Model Assessment of Insulin Resistance(HOMA-IR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Triglyceride(TG);Body Mass Index(BMI); | — |
Countries
China
Contacts
Public ContactShen Can
West China Hospital of Sichuan University
Outcome results
None listed